9- PHARMA MULTI-C...
Follow
Find
39.4K views | +555 today
 
Rescooped by Lionel Reichardt / le Pharmageek from 1- E-HEALTH by PHARMAGEEK - E SANTE par PHARMAGEEK
onto 9- PHARMA MULTI-CHANNEL MARKETING by PHARMAGEEK
Scoop.it!

Pharma MLR "Social Media Scaredy Cats" Don't Trust Their SM Pioneer Employees

Pharma MLR "Social Media Scaredy Cats" Don't Trust Their SM Pioneer Employees | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
At the Social Media, Mobile & Gaming for Pharma conference in New York City this past Wednesday, a discussion about pharma being "committed" to social media took an interesting turn when an attendee "complained" that "every single word that we say...
more...
No comment yet.
9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK
MULTI CHANNEL MARKETING IN PHARMA / MULTICANAL DANS LA PHARMA
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from Bien communiquer
Scoop.it!

Pourquoi certains marketeurs sabotent d’eux-mêmes leurs campagnes digitales

Pourquoi certains marketeurs sabotent d’eux-mêmes leurs campagnes digitales | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Comme le montre une récente étude, si la plupart des marketeurs reconnaissent les immenses opportunités générées par les technologies digitales, quatre freins continuent à ralentir leur adoption et leur mise en œuvre.

Via Isabelle Boucher-Doigneau - Cultureuse
more...
Isabelle Boucher-Doigneau - Cultureuse's curator insight, Today, 11:20 AM

Le marketeur, premier saboteur de ses campagnes ?

A lire :)

Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

Harnessing Social Media Listening for the Pharmaceutical Industry

Harnessing Social Media Listening for the Pharmaceutical Industry | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Changing patient expectations represent a shifting landscape, together with the increasing influence of social media, plus heightened government regulatory activity and a growing trend of alliances and acquisitions.

Pharmaceutical companies need to respond dynamically to this evolution by implementing new business models. Next generation business models must address a number of key factors to position themselves for long-term success, one of which is to listen and ultimately engage in meaningful dialogue with consumers and stakeholders.

The benefits to be gained from social media listening far outweigh any concerns for the pharma sector, and in this whitepaper created with our friends over at Brandwatch, we seek to explore;

  • Key challenges facing pharmaceutical companies in their forays into social listening such as AE reporting and ROI measurement
  • Benefits of social listening illustrated with reference to a number of case studies drawn from a selection of therapy areas
  • Recommendations around how to get started and the role Brandwatch and PharmiWeb Solutions can take to help you achieve business success

How can you derive actionable insights from your listening activity? PharmiWeb Solutions have partnered with Brandwatch to provide a highly specialized solution tailored to the life sciences sector.



Via Plus91
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from "Pharma industry, patients & social media | Patient-focused drug development & Precision medicine | Multichannel marketing to healthcare professionals" by VAB Traductions
Scoop.it!

What is the objective of DTC marketing?

What is the objective of DTC marketing? | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
POST SUMMARY: DTC marketing’s objective, in the past, was to drive new Rx’s.  Marketers ran commercials and patients went into their doctor to request the product or get a sample, but today the environment in which we market is more complex and filled with a lot of noise.  So how do DTC marketers cut through to ensure their marketing is still relevant?

Via VAB Traductions
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

Is Social Media Worth the Risk for Pharma?

Is Social Media Worth the Risk for Pharma? | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

It’s a question that comes up all the time in my discussions with senior industry executives – is social media actually worth the risk for a sector as heavily regulated as the pharmaceutical industry?

And while some may roll their eyes and denounce pharma as being backward for asking such a question, I don’t agree – it’s a great question and an extremely valid one. Every business decision has to consider risk versus benefit.

But here’s the problem with measuring that risk-benefit ratio: you need to consider the timeframe. It’s true for every decision ever made, no matter how big or small and it also applies to our personal lives. For example, there is a small but finite risk involved every time you travel in a car, train, boat or plane. If I considered that risk, versus the benefit of travelling to business meetings, over just a 24h timeframe I’d probably never bother (and also be perceived as being a little odd!). But at least some of those meetings will turn into mutually beneficial commercial relationships, so the benefit far outweighs the risk for me when you look at it over the longer-term. In fact, there is a longer-term risk, to my livelihood, from not travelling that is more worrying than the immediate one.

So if you’re just looking at the short-term risk-benefit ratio of anything you’re getting a distorted picture. This is exactly how I challenge people in pharma to look at it when they ask me about risk.

The benefits of social media engagement by pharmaceutical companies are very clear to me and, at a simple level, they are twofold.

Firstly, the relationships formed via social media engagement translate to the offline world. I know this because I’ve seen it happen many times with my business. Many of the healthcare influencers (patients / patient organisation leaders, industry executives, influential healthcare providers, media etc.) who I know on first-name terms initially met me via social media. When access to these people is often a major barrier for pharmaceutical companies the value of social media cannot be ignored.

Secondly, the kind of direct feedback you can receive via social media is fantastically useful – both directly online and, in line with the way it builds ‘real-world’ relationships outlined above, from subsequent offline conversations. In the information age, this kind of input that can only be obtained by being well-connected, can deliver a critical advantage. Social media listening is a start, but engaging delivers a whole new level of intelligence.

So that’s it – access to key customers and unique insights are the two main benefits for pharma using social media, in my view. Both have a major impact on the bottom line success of products.

And the immediate risks of engaging online? Most of them carry even bigger risks from not engaging in the longer-term.

For example, companies worry about picking up adverse events about their products, necessitating subsequent action. Yes – this might well happen, but what if people are having adverse events when using your products and you’re not picking them up? Where does that lead?

Or the notion that by taking part in social media activity, your critics might start to attack you. If you have such vocal critics the reality is they are already attacking you online and, unless you listen, you can’t take the necessary action to remedy it. So by not engaging, the reputational risk to your business – and associated commercial risk – is massive.

I could go on and on, but hopefully you get my point.

Online social engagement is here to stay. It’s only going to get more and more important as a conduit for connectivity and information sharing. So next time someone in pharma asks you if social media is worth the risk, ask them to cast their gaze a bit further down the line to a point when all their competitors are engaging online.

Is not engaging on social media then worth the risk?



Via Plus91
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Can #Pharma Conquer The Consumer The Way Apple Did? This App Might Help #hcsm #hcsmeu #hcsmeufr

Can #Pharma Conquer The Consumer The Way Apple Did? This App Might Help #hcsm #hcsmeu #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
http://bionicly.com/digital-health-hype-cycle/
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Hackathon Novartis : que le code commence ! #hcsmeufr #esantehack

Hackathon Novartis : que le code commence ! #hcsmeufr #esantehack | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Hackathon e-santé novartis
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Biotech, Pharmas and ideas
Scoop.it!

Google To Build Robotic Surgery Platform With Johnson & Johnson #hcsmeufr #hcsmeu

Google To Build Robotic Surgery Platform With Johnson & Johnson #hcsmeufr #hcsmeu | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
 Google and Johnson & Johnson have announced that the will team up to develop an advanced, robot-assisted surgery platform.

Via Herve Ansanay
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Le marché pharmaceutique français en 2014 - source @GERS_GIE #hcsmeufr #pharma

Le marché pharmaceutique français en 2014 - source @GERS_GIE #hcsmeufr #pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Lire aussi le storify de l'AG https://storify.com/GERS_GIE/le-marche-pharmaceutique-francais-2014-ag-du-gie-g

Lionel Reichardt / le Pharmageek's insight:

Intéressante infographie diffusée hier par @GERS_GIE à l'occasion de leur Assemblée Générale

more...
Jerome Leleu's curator insight, March 27, 3:05 AM

ajouter votre aperçu ...

Tahamida Mze's curator insight, March 27, 4:07 AM

ajouter votre aperçu ...

Helene Decourteix's curator insight, March 27, 5:20 AM

Le marché pharmaceutique français en 2014 - source @GERS_GIE 

Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Blogueurs vs Journalistes : qui est le plus influent à l’heure du web 2.0 ? #hcsmeufr

Blogueurs vs Journalistes : qui est le plus influent à l’heure du web 2.0 ? #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Face à la digitalisation de l'information et à la démocratisation de la création de son contenu, les blogueurs gagnent en influence à l'ère du web 2.0.
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

LE MARCHE PHARMACEUTIQUE FRANÇAIS 2014 - #laDATAréférence cc @GERS_GIE #hcsmeufr

#AGGersGie - 26 mars 2015 - PARIS #laDATAréférence
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Buzz e-sante
Scoop.it!

Dailypso : application pour mieux comprendre et gérer son Psoriasis

Dailypso : application pour mieux comprendre et gérer son Psoriasis | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Pour accompagner les patients dans la gestion au quotidien de leur psoriasis, le laboratoire Janssen lance une nouvelle version de l'application mobile DailyPso. Présentation. Développée en partena...

Via Rémy TESTON
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Financial Social Media
Scoop.it!

How pharma can generate ROI on social media

How pharma can generate ROI on social media | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
For companies in the pharma sector, LinkedIn represents a vastly under-used opportunity to conduct business and generate that elusive return-on-investment online . How does pharma get a return on investment on social media?

Via Josepf J Haslam
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health, Digital Health, mHealth, Digital Pharma, hcsm latest trends and news (in English)
Scoop.it!

INTERVIEW: Accenture's David Logue talks digital pharma

INTERVIEW: Accenture's David Logue talks digital pharma
PharmaTimes
DL: Pharma marketing organisations are often set up with a dependency on colleagues in the technology function to deliver digital experiences.

Via eMedToday, Celine Sportisse
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Le monde digital de 2015 à 2025 : « Toute résistance est inutile, vous serez assimilés ! » #hcsmeufr

Le monde digital de 2015 à 2025 : « Toute résistance est inutile, vous serez assimilés ! » #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

#hcsmeufrNous vivons aujourd’hui au rythme de la frénésie digitale ! Une innovation en chasse une autre, et l’accélération de la vitesse d’adoption des nouvelles technologies questionne sur les limites de cette (r)évolution continue.

more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from parcours de soins
Scoop.it!

AbbVie édite un Livre Blanc sur la prévention des maladies ... - Pharmaceutiques

AbbVie édite un Livre Blanc sur la prévention des maladies ... - Pharmaceutiques | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
AbbVie a publié mi-mars un Livre Blanc européen "pour le développement durable des systèmes de soins". Le document établi pour la France s'intéresse au renforcement de la prévention secondaire et tertiaire des maladies chroniques.

Via Marie Françoise de Roulhac
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Hospitals: Trends in Branding and Marketing
Scoop.it!

Infographic: The State of the Connected Patient in 2015

Infographic: The State of the Connected Patient in 2015 | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
The State of the Connected Patient report examines how patients are currently connecting with their providers, as well as future technology requests.

Via Art Jones, eMedToday
more...
Art Jones's curator insight, March 29, 11:26 AM

"While traditional communication channels remain popular among older patients, the next generation of younger patients known as millennials are interested in utilizing more digital health tools to enhance their patient experience, according to a recent Salesforce report. "

Rescooped by Lionel Reichardt / le Pharmageek from Digital marketing pharma
Scoop.it!

Leo Pharma sets out its social media principles

Leo Pharma sets out its social media principles | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Also expands its use of Twitter with two new accounts


Via Olivier Delannoy
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

e-santé : conférence, convergence et networking #hcsmeufr

e-santé : conférence, convergence et networking #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
e-santé : conférence, convergence et networking #hcsmeufr
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from "Pharma industry, patients & social media | Patient-focused drug development & Precision medicine | Multichannel marketing to healthcare professionals" by VAB Traductions
Scoop.it!

Up To 90 Percent Of Adverse Reactions Unreported, Pharma Companies Search Social Media To Make Drugs Safer

Up To 90 Percent Of Adverse Reactions Unreported, Pharma Companies Search Social Media To Make Drugs Safer | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

"Some reports show that up to nine out of 10 adverse reactions from drugs go unreported. In an effort to find those possible adverse drug reactions in medications, pharmaceutical companies are reportedly searching social media for a better chance at learning of potential adverse drug reactions. There are many potential adverse drug reactions that patients might not think of to report to their health care provider, according to The Pharmaceutical Journal.

“Adverse drug reactions (ADRs) are grossly under reported by everyone, including healthcare professionals, but particularly so by patients,” David Lewis, head of global safety at the Switzerland-based pharmaceutical company Novartis. Novartis is working on a three-year project called Web-RADR (Recognizing Adverse Drug Reactions) that will in part use social media information to determine if there are aftermarket adverse drug reactions in various medications. The program even uses the hashtag #pharmacovigilance."



Via Plus91, VAB Traductions
more...
EmmanuelGrunenberger's curator insight, March 23, 1:01 PM

Not so suprising, when did you report Adverse Reaction for the last time ? Part of the answer of tomorrow's Pharmacovigilance is in Social Media.

Remember: Twitter is already faster and accurate predction of epidemic flu compared to official observatory. 

Nicole Gillen's curator insight, March 24, 8:09 AM

totally agree.  And I wrote on the same recently: http://blogs.csc.com/2015/03/09/pharmacovigilance-taps-social-media/

Rescooped by Lionel Reichardt / le Pharmageek from Digital Pharma news
Scoop.it!

Apple and Google stake a claim on big pharma’s turf - FT.com

Apple and Google stake a claim on big pharma’s turf - FT.com | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had signed up to take part in five inaugural studies involving some of the US’s most respected medical institutions. A Harvard-affiliate

Via Richard Meyer, Rémy TESTON
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health, Digital Health, mHealth, Digital Pharma, hcsm latest trends and news (in English)
Scoop.it!

Key Digital Health Trends for EU Pharma - Manhattan Research #hcsmeu #hcsmeufr

Key Digital Health Trends for EU Pharma - Manhattan Research #hcsmeu #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Key Digital Health Trends for EU Pharma Marketers- Manhattan Research

Via Alexandre Gultzgoff, COUCH. , Celine Sportisse
more...
rob halkes's curator insight, March 27, 10:00 AM

How fast is heathcare realy changed?

Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

REGARDS CROISES SUR LE SYSTEME DE SANTE FRANÇAIS #regardscroises cc @gers_gie #hcsmeufr

#regardscroisés - 26 mars 2015 - PARIS
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

CARMELIA est un outil de suivi connecté à destination des patients atteints d’une MICI #hcsmeufr (maladie inflammatoire chronique de l'intestin) et leur professionnels de santé.

CARMELIA est un outil de suivi connecté à destination des patients atteints d’une MICI #hcsmeufr (maladie inflammatoire chronique de l'intestin) et leur professionnels de santé. | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
CARMELIA est un outil de suivi connecté à destination des patients atteints d’une MICI (maladie inflammatoire chronique de l'intestin) et leur professionnels de santé.
more...
so larn's curator insight, March 25, 10:14 AM

Fière que ce soit finalement sorti !